GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » Short Interest

BTAX (Biostax) Short Interest


View and export this data going back to . Start your Free Trial

What is Biostax Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Biostax's Short Interest

For the Biotechnology subindustry, Biostax's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biostax's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biostax's Short Interest distribution charts can be found below:

* The bar in red indicates where Biostax's Short Interest falls into.


;
;

Biostax Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » Short Interest
Comparable Companies
XSNX GRTSQ PXMD MTEM EFTR NTBLQ PPCB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269
Traded in Other Exchanges
N/A
Address
2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792
Website
https://www.biostaxcorp.com
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Executives
Glen A Farmer officer: Chief Financial Officer 20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust 10 percent owner 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky director, 10 percent owner 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson 10 percent owner, officer: COO and ICEO and IP 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley other: Member of 10% owner group 410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd other: Member of 10% owner group 1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp 10 percent owner, other: Member of 10% owner group 100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi other: Member of 10% owner group 2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes other: Member of 10% owner group 9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth other: Member of 10% owner group 9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz other: Member of 10% owner group 100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd other: Member of 10% owner group 20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko other: Member of 10% owner group 515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc other: Member of 10% owner group 2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey other: Member of 10% owner group 401 FIRST STREET, LOS ALTOS CA 94022